Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol and Hydrocortisone Ointment for Facial and Intertriginous Psoriasis
NCT00640822Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Feb 2008
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of AKP01, Alkindi Sprinkle in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Feb 2008; status: completed.
02
Drugs
AKP01Alkindi Sprinkle
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00640822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640822.